195 related articles for article (PubMed ID: 16723212)
1. PET imaging of the basal ganglia.
Laihinen A; Halsband U
J Physiol Paris; 2006 Jun; 99(4-6):406-13. PubMed ID: 16723212
[TBL] [Abstract][Full Text] [Related]
2. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
3. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET.
Boecker H; Ceballos-Baumann A; Bartenstein P; Weindl A; Siebner HR; Fassbender T; Munz F; Schwaiger M; Conrad B
Brain; 1999 Sep; 122 ( Pt 9)():1651-65. PubMed ID: 10468505
[TBL] [Abstract][Full Text] [Related]
4. Simon effect and attention in Parkinson's disease: a comparison with Huntington's disease and Tourette's syndrome.
Cope MT; Georgiou N; Bradshaw JL; Iansek R; Phillips JG
J Clin Exp Neuropsychol; 1996 Apr; 18(2):276-90. PubMed ID: 8780962
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography and central neurotransmitter systems in movement disorders.
Weeks RA; Brooks DJ
Fundam Clin Pharmacol; 1994; 8(6):503-17. PubMed ID: 7721227
[TBL] [Abstract][Full Text] [Related]
6. [Functional imaging for disorders of basal ganglia].
Otsuka M; Taniwaki T
Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m HMPAO imaging in patients with basal ganglia disease.
Smith FW; Gemmell HG; Sharp PF; Besson JA
Br J Radiol; 1988 Oct; 61(730):914-20. PubMed ID: 2973362
[TBL] [Abstract][Full Text] [Related]
8. Asymmetry of basal ganglia perfusion in Tourette's syndrome shown by technetium-99m-HMPAO SPECT.
Klieger PS; Fett KA; Dimitsopulos T; Kurlan R
J Nucl Med; 1997 Feb; 38(2):188-91. PubMed ID: 9025732
[TBL] [Abstract][Full Text] [Related]
9. Single photon emission computed tomography (SPECT) in a patient with Wilson's disease.
Komine Y; Shundo F; Shirahata N; Takahashi K; Fujita T
Jpn J Med; 1988 Aug; 27(3):309-10. PubMed ID: 3264035
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in Parkinson's disease and other movement disorders.
Smith KM; Dahodwala N
Exp Neurol; 2014 Sep; 259():44-56. PubMed ID: 24681088
[TBL] [Abstract][Full Text] [Related]
11. Basal ganglia mechanisms underlying precision grip force control.
Prodoehl J; Corcos DM; Vaillancourt DE
Neurosci Biobehav Rev; 2009 Jun; 33(6):900-8. PubMed ID: 19428499
[TBL] [Abstract][Full Text] [Related]
12. [Epidural anesthesia and analgesia in a patient with cerebral manifestations of Wilson's disease].
Cuello Azcarate JJ; García Hernández E; González Rodríguez JL
Rev Esp Anestesiol Reanim; 2005 Oct; 52(8):505-6. PubMed ID: 16281749
[No Abstract] [Full Text] [Related]
13. The role of basal ganglia in rhythmic movement.
Freund HJ; Hefter H
Adv Neurol; 1993; 60():88-92. PubMed ID: 8420222
[No Abstract] [Full Text] [Related]
14. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
Saur HB; Bartenstein P; Schober O; Oberwittler C; Lerch H; Masur H
Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375
[TBL] [Abstract][Full Text] [Related]
15. The role of the basal ganglia in motor control: contributions from PET.
Brooks DJ
J Neurol Sci; 1995 Jan; 128(1):1-13. PubMed ID: 7722526
[TBL] [Abstract][Full Text] [Related]
16. Cannabis in movement disorders.
Müller-Vahl KR; Kolbe H; Schneider U; Emrich HM
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():23-7. PubMed ID: 10627163
[TBL] [Abstract][Full Text] [Related]
17. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis.
Mink JW
Pediatr Neurol; 2001 Sep; 25(3):190-8. PubMed ID: 11587872
[TBL] [Abstract][Full Text] [Related]
18. Basal ganglia function during normal and parkinsonian movement. PET activation studies.
Brooks DJ
Adv Neurol; 1996; 69():433-41. PubMed ID: 8615163
[No Abstract] [Full Text] [Related]
19. The endogenous opioid system in neurological disorders of the basal ganglia.
Sandyk R
Life Sci; 1985 Nov; 37(18):1655-63. PubMed ID: 2865665
[TBL] [Abstract][Full Text] [Related]
20. Movement disorders in the psychiatric patient.
Moros DA; Yahr MD
Hosp Community Psychiatry; 1984 Apr; 35(4):377-83. PubMed ID: 6232196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
